TrialBlood2013

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.

Heinz Gisslinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.